Literature DB >> 22311377

Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.

Bruno Augusto Benevenuto de Andrade1, Jorge Esquiche León, Román Carlos, Wilson Delgado-Azañero, Adalberto Mosqueda-Taylor, Oslei Paes de Almeida.   

Abstract

The acquisition of abnormalities at G1/S is considered a crucial step in the genesis and progression of melanoma. The expression of cell cycle regulators has also been used in various neoplasms as an adjunct to diagnosis. The aim of this study was to compare the expression of p16, p21, p27 and cyclin D1 in oral nevi and melanomas. Expression of these cell cycle regulatory proteins was evaluated by immunohistochemistry in 51 oral melanocytic lesions, including 38 intramucosal nevi and 13 primary oral melanomas. p16 and p27 were highly expressed in intramucosal nevi, whereas p21 and cyclin D1 expression was higher in oral melanomas. The results indicate that p21 and cyclin D1 may be involved in the development of oral melanomas, and eventually they may be useful in the differential diagnoses of oral benign and malignant melanocytic lesions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311377      PMCID: PMC3422579          DOI: 10.1007/s12105-012-0334-y

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  29 in total

1.  Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.

Authors:  T Nagasaka; R Lai; L J Medeiros; R K Brynes; A McCourty; T Harada; M Saddik
Journal:  Am J Dermatopathol       Date:  1999-04       Impact factor: 1.533

2.  Cyclin D1 is a candidate oncogene in cutaneous melanoma.

Authors:  Edward R Sauter; Un-Cheol Yeo; Andrea von Stemm; Weizhu Zhu; Samuel Litwin; David S Tichansky; Giuseppa Pistritto; Mark Nesbit; Dan Pinkel; Meenhard Herlyn; Boris C Bastian
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

3.  Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.

Authors:  Qing Li; Michael Murphy; Jeffrey Ross; Christine Sheehan; J Andrew Carlson
Journal:  J Cutan Pathol       Date:  2004-11       Impact factor: 1.587

4.  Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa.

Authors:  N Tanaka; T Odajima; M Mimura; K Ogi; H Dehari; Y Kimijima; G Kohama
Journal:  Oral Oncol       Date:  2001-04       Impact factor: 5.337

5.  Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.

Authors:  G M Maelandsmo; R Holm; O Fodstad; R S Kerbel; V A Flørenes
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors.

Authors:  Manju L Prasad; Snehal G Patel; Andrew G Huvos; Jatin P Shah; Klaus J Busam
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

7.  Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression.

Authors:  Paola Ghiorzo; Michela Mantelli; Sara Gargiulo; Claudia Gramigni; Lorenza Pastorino; Barbara Banelli; Barbara Villaggio; Maria Cristina Coccia; Angela Rita Sementa; Cecilia Garrè; Giovanna Bianchi-Scarrà
Journal:  Hum Pathol       Date:  2004-08       Impact factor: 3.466

Review 8.  Molecular events in melanoma development and progression.

Authors:  F Meier; K Satyamoorthy; M Nesbit; M Y Hsu; B Schittek; C Garbe; M Herlyn
Journal:  Front Biosci       Date:  1998-09-15

9.  Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.

Authors:  Doina Ivan; A Hafeez Diwan; Francisco J Esteva; Victor G Prieto
Journal:  Mod Pathol       Date:  2004-07       Impact factor: 7.842

10.  p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.

Authors:  J M Karjalainen; M J Eskelinen; J K Kellokoski; M Reinikainen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  11 in total

1.  Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Authors:  Raghavendra Gowda; Saketh S Dinavahi; Soumya Iyer; Shubhadeep Banerjee; Rogerio I Neves; Colette R Pameijer; Gavin P Robertson
Journal:  Nanomedicine       Date:  2018-01-06       Impact factor: 5.307

Review 2.  Primary amelanotic mucosal melanoma of the oronasal region: report of two new cases and literature review.

Authors:  Luiz Fernando Barbosa de Paulo; João Paulo Silva Servato; Roberta Rezende Rosa; Maiolino Thomaz Fonseca Oliveira; Paulo Rogério de Faria; Sindeval José da Silva; Sergio Vitorino Cardoso; Adriano Mota Loyola
Journal:  Oral Maxillofac Surg       Date:  2015-05-03

3.  Expression of p16 protein in infantile hemangioma.

Authors:  Shi Wang; Wei Zheng
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

4.  Cyclin-dependent kinase inhibitors, p16 and p27, demonstrate different expression patterns in thymoma and thymic carcinoma.

Authors:  Mutsuko Omatsu; Toshiaki Kunimura; Tetsuya Mikogami; Akira Shiokawa; Atsuko Masunaga; Tomoko Nagai; Akihiko Kitami; Takashi Suzuki; Mitsutaka Kadokura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-18

5.  The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Authors:  Laura Vízkeleti; Szilvia Ecsedi; Zsuzsa Rákosy; Adrienn Orosz; Viktória Lázár; Gabriella Emri; Viktória Koroknai; Tímea Kiss; Róza Ádány; Margit Balázs
Journal:  Tumour Biol       Date:  2012-09-23

6.  Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.

Authors:  Huanrong Hu; Zhen Dong; Peng Tan; Yanli Zhang; Lichao Liu; Liqun Yang; Yaling Liu; Hongjuan Cui
Journal:  Oncotarget       Date:  2016-01-19

7.  Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Ru Zhao
Journal:  Oncol Rep       Date:  2017-03-30       Impact factor: 3.906

8.  p16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi.

Authors:  Laura M Chang; David S Cassarino
Journal:  ISRN Dermatol       Date:  2014-01-22

9.  Stimulation of the proliferation of human normal esophageal epithelial cells by fumonisin B1 and its mechanism.

Authors:  Shao-Kang Wang; Ting-Ting Wang; Gui-Ling Huang; Ruo-Fu Shi; Li-Gang Yang; Gui-Ju Sun
Journal:  Exp Ther Med       Date:  2013-10-25       Impact factor: 2.447

10.  Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.

Authors:  Changlei Yao; Hongfa Li; Weitao Zhang
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Mar-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.